PURE Bioscience, Inc. (PURE) Shareholders’ equity 2012–2025
PURE Bioscience, Inc. (PURE) shareholders’ equity at each fiscal year-end, per SEC filings.
-$5.1MFY2025 · since FY2012: $818,000 → -$5.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.1M | -78.6% |
| FY2024 | -$2.9M | -1152.9% |
| FY2023 | $272,000 | -93.0% |
| FY2022 | $3.9M | +17.3% |
| FY2021 | $3.3M | -30.7% |
| FY2020 | $4.8M | +304.3% |
| FY2019 | $1.2M | -7.1% |
| FY2018 | $1.3M | -0.7% |
| FY2017 | $1.3M | — |
| FY2012 | $818,000 | — |
Source: SEC XBRL filings · For reference only · Not investment advice